JF
MRNA icon

Jump Financial’s Moderna MRNA Stock Holding History

Jump Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.89M Buy
+27,031
New +$1.4M 0.02% 933
2026
Q1 		– Sell
-625,893
Closed -$18.5M – 2211
2025
Q4 		$18.5M Buy
625,893
+127,433
+26% +$3.46M 0.23% 101
2025
Q3 		$12.9M Buy
498,460
+473,788
+1,920% +$13.2M 0.15% 171
2025
Q2 		$681K Sell
24,672
-877,755
-97% -$23.1M 0.01% 1123
2025
Q1 		$25.6M Buy
902,427
+886,567
+5,590% +$31.5M 0.34% 67
2024
Q4 		$659K Sell
15,860
-57,886
-78% -$2.77M 0.01% 951
2024
Q3 		$4.93M Buy
73,746
+46,487
+171% +$4.27M 0.1% 232
2024
Q2 		$3.24M Sell
27,259
-12,870
-32% -$1.63M 0.06% 392
2024
Q1 		$4.28M Buy
40,129
+26,294
+190% +$2.65M 0.12% 167
2023
Q4 		$1.38M Buy
13,835
+11,080
+402% +$932K 0.04% 545
2023
Q3 		$285K Buy
+2,755
New +$307K 0.01% 1338
2022
Q4 		– Sell
-4,503
Closed -$532K – 1864
2022
Q3 		$532K Buy
+4,503
New +$683K 0.02% 876
2022
Q2 		– Sell
-2,080
Closed -$358K – 1863
2022
Q1 		$358K Sell
2,080
-1,405
-40% -$237K 0.02% 975
2021
Q4 		$885K Buy
+3,485
New +$1.02M 0.06% 432

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Jump Financial's MRNA Position: Q2 2026 in Review

Jump Financial opened a new position in Moderna (MRNA) in Q2 2026: 27,031 shares worth $1.89M. The stake represents 0.02% of the portfolio and ranks #933 among its holdings. This is a return to the name: Jump Financial previously reported a position in MRNA as recently as Q4 2025.

Jump Financial first reported a position in MRNA in Q4 2021 and has held it in 14 quarters since. The position peaked at $25.6M in Q1 2025. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Jump Financial held 27,031 shares of Moderna worth $1.89M as of Q2 2026.
  • Moderna was a new Jump Financial position in Q2 2026.
  • Moderna made up 0.02% of Jump Financial's portfolio in Q2 2026, its #933 holding.
  • Jump Financial first reported a position in Moderna in Q4 2021 and has held it in 14 quarters since.
  • Jump Financial's Moderna position peaked at $25.6M in Q1 2025.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.